PRLD: Psyros POC platform advances with new funding, strong industry interest, and robust cash position

About this update from Prolight Diagnostics Ab

Prolight Diagnostics advanced its Psyros POC platform, secured a SEK 17 million grant, and completed a SEK 113 million write-down. No sales were reported, but financing strengthened cash reserves to SEK 32.4 million. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Prolight Diagnostics Ab